Akari Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $25 |
Gross Profit | -1 | |||
EBITDA | -4,490 | -7,322 | -1,845 | -3,650 |
EBIT | -3,119 | -3,648 | ||
Net Income | -5,336 | -6,361 | -1,895 | -3,705 |
Net Change In Cash | 0 | 0 | 0 | 25 |
Free Cash Flow | -891 | -2,101 | -3,256 | -2,150 |
Cash | 5,203 | 2,484 | 2,711 | 2,582 |
Basic Shares | 841 | 816 | 393 | 341 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -13 | -4 | -3 | |
EBITDA | -17,275 | -19,533 | -16,802 | -23,084 |
EBIT | -19,547 | -16,806 | -23,088 | |
Net Income | -17,298 | -19,791 | -10,008 | -17,748 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -10,568 | -12,552 | -16,432 | -21,504 |
Cash | 5,203 | 2,599 | 3,845 | 13,250 |
Basic Shares | 841 | 298 | 122 | 78 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.20 |
2025-06-30 | -$0.06 |
2025-03-31 | -$0.19 |
2024-09-30 | -$9.49 |
